Document is current
Any future updates will be listed below
-
Authors
Ahola, Aila J.
Mutter, Stefan
Forsblom, Carol https://orcid.org/0000-0002-3354-7454
Harjutsalo, Valma
Groop, Per-Henrik https://orcid.org/0000-0003-4055-6954
-
Funding
Funding for this research was provided by:
Academy of Finland
Novo Nordisk Fonden (NNF14SA0003)
Signe ja Ane Gyllenbergin Säätiö
Wilhelm och Else Stockmanns Stiftelse
- License Information
-
More Information
Article History
Received: 20 June 2019
Accepted: 8 December 2019
First Online: 27 December 2019
Competing interests
: Professor Per-Henrik Groop has received investigator-initiated grants from Eli Lilly and Roche, is an advisory board member for AbbVie, Astellas, Astra Zeneca, Boehringer-Ingelheim, Cebix, Eli Lilly, Janssen, MSD, Medscape, Mundipharma, Novartis, Novo Nordisk, and Sanofi. He has received lecture honoraria from Astellas, Astra Zeneca, Boehringer-Ingelheim, Eli Lilly, Elo Water, Genzyme, MSD, Mundipharma, Novartis, Novo Nordisk, PeerVoice, and Sanofi. All other authors declare no conflicts of interest.
